Prostate cancer is the most common solid-organ malignancy among American men.
It is currently most commonly diagnosed on random systematic biopsies prompted by elevated serum PSA levels. Multi-parametric MRI (MP-MRI) of the prostate has emerged as an anatomic and functional imaging modality, which offers accurate detection, localization and staging of prostate cancer. Recently, MP-MRI has gained an increasing role in guiding biopsies to sites of abnormality and in monitoring patients on active surveillance. Here, we discuss the historical development, current role, and potential future directions of MP-MRI in the diagnosis of prostate cancer.
Written by:
Rais-Bahrami S, Turkbey B, Grant KB, Pinto PA, Choyke PL. Are you the author?
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10 - CRC, Bethesda, MD, 20892, USA.
Reference: Curr Urol Rep. 2014 Mar;15(3):387.
doi: 10.1007/s11934-013-0387-9
PubMed Abstract
PMID: 24430169
UroToday.com Prostate Cancer Section
